Skip to main content

Table 2 Serum lipids, lipoproteins, apolipoproteins and LPL mass and LPL and HL activities in postheparin and preheparin plasma samples

From: Lipoprotein lipase activity and mass, apolipoprotein C-II mass and polymorphisms of apolipoproteins E and A5 in subjects with prior acute hypertriglyceridaemic pancreatitis

 

HP

N = 24

HTG

N = 31

p

Total cholesterol

6.96 ± 3.72

6.56 ± 1.68

NS

TG

3.53 (2.07–8.75)

4.87 (2.70–8.41)

NS

VLDL-Chol

0.83 ± 0.44

0.91 ± 0.47

NS

HDL-Chol

0.91 ± 0.49

0.88 ± 0.39

NS

LDL-Chol

2.95 ± 1.47

3.28 ± 1.40

NS

VLDL-TG

1.39 (1.06–1.97)

1.41 (1.10–2.32)

NS

HDL-TG

0.34 (0.23–0.46)

0.31 (0.25–0.44)

NS

LDL-TG

0.58 (0.42–0.64)

0.53 (0.41–0.69)

NS

Chylomicron Chol

4.29 ± 5.43

2.17 ± 1.53

NS

Chylomicron TG

5.30 (2.73–11.52)

3.63 (2.30–6.40)

NS

Apo A-I

1.04 ± 0.36

1.10 ± 0.30

NS

Apo B-100

0.91 ± 0.32

0.96 ± 0.27

NS

Apo CII

0.11 ± 0.05

0.13 ± 0.07

NS

Apo CIII

0.17 ± 0.07

0.20 ± 0.09

NS

Apo E

0.09 ± 0.04

0.11 ± 0.06

NS

ApoCIII/ApoCII

2.8 ± 4

1.7 ± 0.7

NS

Apo E Genotype

  

NS

E3/E2

1 (4)

5 (16)

 

E3/E3

19 (79)

22 (73)

 

E3/E4

2 (8)

3 (10)

 

E2/E4

2 (8)

0

 

Apo A-V, allele S19W

8 (32)

7 (23)

NS

LPLactivity

(mU/ml)

69 ± 44

92 ± 44

0.057

HL-activity

(mU/ml)

164 ± 94

194 ± 84

NS

Posth-LPLmass

(ng/ml)

312 ± 192

411 ± 195

0.06

Preh-LPLmass

(ng/ml)

18 ± 11

22 ± 14

NS

  1. Data shown as mean ± SD unless Tg shown as median (IQ range). Units in SI. Note: Chylomicrons were found only in 12 subjects in the group HP and in 21 of the group HTG. Apo E and apo AV genotypes mean number (%).